[Skip navigation] FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
 HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule

First-Time Generics - November 2005

  Generic Drug Name Generic Manufacturer Brand Name Approval Date
1 SODIUM BICARBONATE INJECTION USP, 7.5% (0.9 mEq/ML) AND 8.4% (1 mEq/ML)SYRINGES HOSPIRA, INC. SODIUM BICARBONATE INJECTION, USP 11/9/2005
2 HYDROMORPHONE HYDROCHLORIDE TABLETS USP, 2 MG, 4 MG, AND 8 MG KV PHARMACEUTICAL COMPANY DILAUDID TABLETS 11/9/2005
3 CEFPROZIL TABLETS USP, 250 MG AND 500 MG SANDOZ INC. CEFZIL TABLETS 11/14/2005
4 AZITHROMYCIN TABLETS, 500 MG TEVA PHARMACEUTICALS USA ZITHROMAX TABLETS 11/14/2005
5 AZITHROMYCIN TABLETS, 250 MG TEVA PHARMACEUTICALS USA ZITHROMAX TABLETS 11/14/2005
6 AZITHROMYCIN TABLETS, 600 MG TEVA PHARMACEUTICALS USA ZITHROMAX TABLETS 11/14/2005
7 AZITHROMYCIN TABLETS, 500 MG SANDOZ, INC. ZITHROMAX TABLETS 11/14/2005
8 AZITHROMYCIN TABLETS, 250 MG SANDOZ, INC. ZITHROMAX TABLETS 11/14/2005
9 AZITHROMYCIN TABLETS, 600 MG SANDOZ, INC. ZITHROMAX TABLETS 11/14/2005
10 OFLOXACIN OTIC SOLUTION, 0.3% APOTEX INC. FLOXIN OTIC SOLUTION 11/18/2005
11 PROMETHAZINE HYDROCHLORIDE TABLETS USP, 12.5 MG, 25 MG, AND 50 MG ZYDUS PHARMACEUTICALS USA, INC. PHENERGAN TABLETS 11/18/2005

Back to Top     Back to Approvals

Date created: January 18, 2006

horizonal rule

CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility | HHS Home Page

FDA/Center for Drug Evaluation and Research